Madrid

• A Phase 1 Study of CD19-targeted NEX-T CAR T Cells in Participants with RMS, PMS, or MG(Breakfree-2) Halted
  2023-507820-22-00 3 2024-05-22 Myasthenia gravis (MG)
• A Trial to Study if REGN5837 in Combination with Odronextamab is Safe for Adult Participants with Aggressive B-cell Non-Hodgkin Lymphomas Halted
  2022-502137-26-00 1 2024-05-03 B-cell Non-Hodgkins Lymphoma (B-NHL)
• A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) in Non-Ambulatory and Ambulator … Halted
  2024-512626-28-00 5 2024-03-28 Duchenne Muscular Dystrophy
• A 96-Week, Prospective, Multicenter, Randomised, Double-Blind, Placebo-Controlled, Phase 3 Study to Compare Efficacy and Safety of Masitinib … Halted
  2024-516672-16-00 5 2024-02-02 Multiple Sclerosis
• A randomized, open-label, multicentric, two-arm pivotal trial of SonoCloud-9 combined with carboplatin (CBDCA) vs standard of care lomustine … Halted
  2023-505829-14-00 5 2023-12-22 First recurrence glioblastoma
• Phase 2 Study of CAL02 plus Standard of Care in Severe Community-Acquired Bacterial Pneumonia (SCABP) Halted
  2022-502049-91-00 4 2023-09-26 SEVERE COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA (SCABP)
• A study to investigate pharmacokinetics, safety, and tolerability of Cefepime-Enmetazobactam administered by intra-venous infusion over 2 ho … Halted
  2024-518003-22-00 4 2023-01-20 Complicated urinary tract infections including acute pyelonephritis
• Study of efficacy and safety of JDQ443 single-agent as first-line treatment for patients with locally advanced or metastatic KRAS G12C- muta … Halted
  2024-511708-18-00 4 2022-12-06 Locally advanced or metastatic KRAS G12C-mutated non-small cell lung c
• A Phase I/II study of DYP688 treatment alone in patients with eye cancer and other types of cancers of the skin and mucosal membranes in the … Halted
  2023-509451-14-00 7 2022-11-01 Metastatic uveal melanoma
• Study of efficacy and safety of JDQ443 in comparison with docetaxel in participants with locally advanced or metastatic KRAS G12C mutant non … Halted
  2023-510082-10-00 5 2022-09-05 Advanced non-small cell lung cancer harboring the KRAS G12C mutation
• A Phase 1, Double-blind, Randomized, Three-arm, Parallel Group Study to Compare the Pharmacokinetics and Safety of a Single Subcutaneous Dos … Halted
  2024-519145-30-00 3 2022-03-31 Healthy volunteers
• A phase 1/2 study of subcutaneous blinatumomab administration in adults and adolescents with R/R and MRD+ B-ALL Halted
  2023-506136-32-00 9 2020-10-12 Relapsed or Refractory B cell Precursor Acute Lymphoblastic Leukemia (
• Bioequivalence clinical trial of two formulations of rosuvastatin. Ended
  2026-525230-27-00 2 2026-02-23 Hypercholesterolemia
• OPEN-LABEL PALATABILITY STUDY OF A NOVEL ORODISPERSIBLE PARACETAMOL/IBUPROFEN FORMULATION AFTER A SINGLE ORAL ADMINISTRATION IN HEALTHY SUBJ … Ended
  2025-524274-41-00 3 2026-01-26 Healthy volunteers
• GSK4527226 Open-label Extension Study in Patients with Early Alzheimer's Disease. Ended
  2025-521107-42-00 4 2025-11-25 Alzheimer's Disease
• Randomised, crossover bioequivalence clinical trial of memantine 20 mg capsules versus memantine 20 mg film-coated tablets, after a single o … Ended
  2025-523808-75-00 2 2025-10-24 Alzheimer’s disease
• Bioequivalence clinical trial of two formulations of loperamide. Ended
  2025-523705-14-00 2 2025-10-23 Healthy volunteers
• A Phase 1 Study of ATV-1601, in Patients with Advanced Cancer that have AKT1 E17K Mutations Ended
  2025-521480-12-00 1 2025-10-22 Advanced solid tumors, Breast Cancer
• Bioequivalence clinical trial of two formulations of linagliptin Ended
  2025-523384-37-00 2 2025-10-10 Healthy volunteers
• A First-in-human study to learn how safe the study drug BAY2965501 is, find the best dose (single drug & combination), how it affects the bo … Ended
  2023-507905-33-00 1 2025-09-30 Advanced solid tumors
• RANDOMIZED, CROSSOVER, TWO-PERIOD, COMPARATIVE BIOAVAILABILITY STUDY OF TWO IBUPROFEN FORMULATIONS, AFTER A SINGLE ORAL DOSE OF 400 MG IN SO … Ended
  2025-520852-27-00 3 2025-09-18 Healthy volunteers
• Randomized, open-label, three-period crossover study on the palatability of oral dispersible formulations of Zonisamide in healthy volunteer … Ended
  2025-522297-36-00 3 2025-09-03 Healthy volunteers
• Bioequivalence clinical trial of two formulations of dapagliflozin/metformin Ended
  2024-510791-20-00 2 2025-08-29 Healthy volunteers
• Randomised, crossover bioequivalence clinical trial of escitalopram 10 mg capsules versus escitalopram 10 mg film-coated tablets, after a si … Ended
  2025-522124-26-00 2 2025-08-18 Antidepressants

Showing 2,617–2,640 of 3,550 trials